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Abstract
Background: Human Parainfluenza viruses are a common cause of both upper and lower respiratory tract infections,
particularly in children. Of the four Parainfluenza virus serotypes, Parainfluenza 4 is least well characterised from both
the clinical, epidemiological and genetic perspectives.
Methods: Flocked nose or throat swabs from a previous study investigating viral prevalence in community-based
adults suffering from influenza like illness were used as the basis for this study. Samples in which no virus was detected
using a 16 viral respiratory pathogen real-time PCR panel were barcoded and pyrosequenced using the Roche 454 GS
FLX Titanium chemistry. The sequences were analysed using the VirusHunter bioinformatic pipeline. Sanger sequencing
was used to complete the detected Parainfluenza 4 coding region.
Results: A variant Parainfluenza 4 subtype b strain (QLD-01) was discovered in an otherwise healthy adult who
presented with influenza like illness. Strain QLD-01 shared genomic similarities with both a and b subtypes. The
extent of divergence of this genome from the 5 available whole Parainfluenza 4 genomes impacted the predicted
binding efficiencies of the majority of published Parainfluenza 4 PCR assays.
Conclusions: These findings further support a possible role for Parainfluenza 4 in the aetiology of adult respiratory
disease within the community setting, and highlight the caution needed to be used in designing PCR assays from
limited sequence information or in using proprietary commercial PCR assays.
Keywords: Parainfluenza 4, Community infection, Respiratory tract infection, Influenza like illness, Next generation
sequencing, Virus discovery, PCR, False negative results, Adult
Background
Human parainfluenza viruses are a common cause of both
upper and lower respiratory tract infections, particularly
in children [1-5]. Four serotypes are known, but most
epidemiological and clinical research has been focused
on parainfluenza serotypes 1–3. This has been primarily
due to the poor growth characteristics in cell culture of
parainfluenza 4 (PIV4), the lack of commercial diagnostic
reagents, and historical exclusion from routine diagnostic
testing [3]. Two antigenically distinct PIV4 subtypes,
PIV4a and PIV4b, exist [6]. Functionally and epidemio-
logically, little is known about the two PIV4 subtypes,
however both are capable of co-circulating within the same
population [7]. With the advent of reverse transcription
PCR (RT-PCR), it has become easier to screen for an ex-
panded range of RNA viruses, leading to a re-examination
of PIV4’s epidemiology and role in human disease [2,3,5,8].
The majority of research into PIV4 has focused on children
within the hospital setting, however little information is
available on the role of PIV4 in disease within the broader
community.
Despite the resurgent interest in PIV4, a dearth of
publically available PIV4 sequences, and in particular,
whole genomes, still exists. The lack of appreciable se-
quence information hampers the design and evaluation
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of sensitive research and diagnostic RT-PCR assays,
since these tests are reliant on oligomer homology to
the target sequence. Thus it is imperative to increase the
number of publically available sequences for clinically
relevant pathogens where little information is currently
available, particularly when variant genomes are observed.
Powerful new techniques such as next-generation se-
quencing have been applied to clinical samples over the
last five years with the aims of discovering novel pathogens.
Numerous viruses and variant strains have been identified
using this approach, including a divergent PIV4 subtype
a isolate late in 2013 [9]. Unlike insensitive traditional
virological methods and highly specific RT-PCR, next-
generation sequencing methods have the advantage of
being able to sequence total or targeted DNA and RNA
from samples in an unbiased way, without a priori
knowledge of the possible viral agent(s) present, thus
making them the ideal tool for novel and divergent viral
genome discovery.
In this study, we used a combination of RT-PCR and
next-generation sequencing to identify and characterise
the full coding sequence of a novel PIV4 variant from an
adult participating in a community-based cohort study of
respiratory illness. Furthermore we compared the primer




Samples used for this study were derived from a previous
study [10] investigating viral prevalence in a sub-population
of participants in a community-based, randomised control
trial assessing influenza vaccine effectiveness. Briefly,
flocked nose or throat swabs were collected from otherwise
healthy adults aged from 18–64 years who presented with
influenza-like illness (ILI). ILI was defined as cough, sore
throat, runny nose or nasal congestion and at least one sys-
temic symptom (fever greater/equal than 37.8°C, feverish-
ness, chills or myalgia). In total, 643 samples were screened
for adenovirus, human metapneumovirus, parainfluenza vi-
ruses 1, 2 & 3, respiratory syncytial virus, influenza A and
B, picornaviruses, bocavirus, coronaviruses (OC43, 229E,
NL63 and HKU1) and WU and KI polyomaviruses using
real-time PCR [10]. 299 study samples from which no viral
pathogen was detected were used as templates for novel
virus discovery. Written consent was obtained from all
study participants. The original and current studies were
approved by the Royal Children’s Hospital Human Research
Ethics Committee (Melbourne) and the Human Research
Protection office of Washington University, respectively.
Viral discovery pipeline
Total nucleic acid was extracted from each sample,
subjected to sample-specific barcoded random-priming
cDNA synthesis and then PCR amplified using barcode-
specific primers. Standard library construction and 454
GS FLX Titanium pyrosequencing was performed as
previously described [11]. The sequences were analysed
using the VirusHunter bioinformatic pipeline [12]. In
brief, high quality reads with similarity to viruses at the
nucleotide level or amino acid level were identified using
BlastN and BlastX, respectively.
Genome sequencing & assembly
Individual 454 reads were assembled and mapped against
PIV4 subtype a and PIV4 subtype b reference genomes
M-25 (AB543336) and SKPIV4 (EU627591), respectively.
Walking primers for amplifying and sequencing the
remainder of the genome were designed based on the
assembled contigs and reference genomes (see Additional
file 1). Sanger sequencing was performed on the overlap-
ping amplified cDNA bidirectionally. Contig assembly and
genome characterisation was performed using CLC Bio
Genomics Workbench 6.5 software. (CLC Bio, Denmark)
Phylogenetic analysis was performed using MEGA 5.2
software (http://www.megasoftware.net/) [13]. Recombin-
ation event analyses were performed using the Recombin-
ation Analyses Tool software (https://github.com/ethering/
RAT) [14], with widow sizes of 1719, 800, and 400 applied
to a whole genome alignment using QLD-01 as the
reference.
Results
A sample collected in Melbourne (Australia) from a 49 year
old male produced 32 reads (see Additional file 2) with
highest similarity to PIV4 (83.7-98.3%). Apart from the
presentation with ILI meeting the study case definition, no
other clinical information was recorded in the subject’s
symptom diary. The reads mapped to six singletons and
five contigs of 533, 607, 700, 759, and 904 nt in length, and
showed highest similarity to SKPIV4, against which the
genome walking primers were designed. Final assembly of
the sequenced amplicons yielded a near-complete genome
of 17,160 nt in length, and included the entire coding re-
gion. The sequence was submitted to GenBank as isolate
QLD-01 (KF908238). During the study period, one other
PIV4 detection was observed within the study population.
Genome characterisation
Overall QLD-01 sequence similarity to the existing whole
PIV4 genomes’ concatenated coding regions showed a
similarity ranging from 88.81-97.05%. Phylogenetic ana-
lyses confirmed QLD-01 was a divergent member of the
4b subtype clade (Figure 1), while the second PIV4 clus-
tered within the 4a subtype (Figure 1, KF878965). Predicted
protein similarities indicated QLD-01’s closest homology to
SKPIV4 in most, but not all proteins, with the greatest
variation being found in the V protein (91.30-91.74%). No
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evidence of recombination between QLD-01 and other
isolates was found (see Additional files 3, 4, and 5).
Strain QLD-01 and the recently described divergent
PIV4a isolate DK(459) shared several structural features
identified by Alquezar-Planas et al. [9]; an extended
C-terminal end and a 13 residue stretch within the
globular head of the predicted HN protein, as well as a
57 nt insertion at the 3′ leader non-coding sequence.
These features were not unique to the two isolates, and in
the case of the HN protein, were more common than not
across both genotypes. Conversely, QLD-01 contained
the most divergent residue sequence (91.4-95.0%) of
the PIV4b genotype within the variable C terminal end
(residues 411–451) of the Nucleocapsid protein.
PCR target conservation
Due to the variant nature of QLD-01, a literature search
was undertaken to assess the compatibility of published
PCR primer/probe targets with the isolate. Of the six
assays evaluated [3,5,15-18], four contained mismatches
in their primer/probe sequences, in particular at the 3′
end (Table 1).
Discussion
Improvements in sequencing and detection technologies
over the past 15 years have led to increasing detection
rates of existing, neglected, and unknown pathogens. The
existence of PIV4 has been known since 1959; however
only recently has PIV4 been more appreciated as a re-
spiratory pathogen in its own right through the use of
modern molecular methods [1-5,8]. Modern molecular
diagnostics heavily rely on PCR-based techniques. Be-
cause of their high specificity, these same methods are
susceptible to decreased sensitivity or even false negative
results when confronted with even minor changes in tar-
get sequences. This limitation is particularly relevant to
clinically important pathogens for which little sequence
data are available to guide PCR assay development and
ongoing evaluation.
The variant PIV4 isolate described in this study is the
most divergent of the five available whole genome se-
quences. Thus it is not surprising that four of the six
evaluated published PCR assays contained potentially
deleterious mismatches with the isolate. In particular,
all four assays contain mismatches at or near their
primers’ 3′ ends, which are especially sensitive to incor-
rect base pairing and would potentially lead to decreased
primer binding efficiency, and in conjunction with the
other primer mismatches, false negative results. These
mismatches illustrate the difficulty in designing sensitive
PCR assays based on very limited sequence information.
Additionally, the use of commercial assays for which pri-
mer sequences are not readily available, such as those used
in recent PIV4 epidemiological studies [1,8], should be
used with the understanding that there is no capacity to
evaluate the assays’ target sequence conservation as new
data on emerging variant viral strains becomes available.
Isolate QLD-01 was found in the upper respiratory
tract of an adult with ILI but no other known conditions.
It was the sole virus detected, despite extensive screening
for other known and unknown respiratory pathogens, thus
supporting a potential role as the aetiological agent of the
subject’s ILI symptoms. Recent studies have reported
PIV4 infections associated with both lower and upper
respiratory tract symptoms within the hospital setting
[1-5,8]. This study provides further evidence of PIV4’s
possible involvement in upper respiratory tract infec-
tions in otherwise healthy adults within the community
setting.
In regard to its genomic structure, QLD-01’s highest
similarity was to isolate SKPIV4. However its overall
genomic and NP C-terminal end divergence separate it
from SKPIV4 and other PIV4b genomes. In other para-
influenza viruses, the NP C terminus binds the protein-
associated viral RNA to the RNA polymerase [19], thus
QLD-01’s variant C-terminal end may alter the isolate’s
viral RNA synthesis kinetics. Isolate QLD-01’s shared
Figure 1 Phylogenetic tree of concatenated full-genome
PIV4 ORFs, including QLD-01. Maximum likelihood analyses of
concatenated NP, P, M, F, HN and L open reading frames of PIV4
isolates AB543337, AB543336, KF483663, JQ241176, EU627591,
KF878965, KF908238 using the Tamura-Nei substitution model
with 1000 bootstrap replicates. Scale represents estimated nucleotide
substitutions per sequence position. This study’s genome is indicated
by a filled circle.
Table 1 PIV4 PCR oligomer mismatches to isolate QLD-01
Primer name Sequence (5′-3′) Study
PI4P+ CTGAACGGTTGCATTCAGGT [3]
PIASB+ AACCAGGGAAACAGAGCTC [3]
LPW 1779 GTGTCTGATCCCATA AGCAGC [5]
PIV-4 Reverse GCATGTTCTGCATCTCTGGA [16]
PIV 4 Forward CAAATGATCCACAGCAAAGATTC [18]
PIV 4 Reverse ATGTGGCCTGTAAGGAAAGCA [18]
PIV 4 Probe GTATCATCATCTGCCAAATCGGCAATTAAACA [18]
Published PIV4 primer and probe sequences with mismatches to isolate
QLD-01 underlined and in bold.
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genomic features with both its closest PIV4b homologue
and the divergent PIV4a raises the possibility of recom-
bination events occurring between the viral subtypes,
however no conclusive evidence was observed to support
this hypothesis.
Conclusions
In this study, the utility of a combined RT-PCR and
next-generation sequencing approach to identifying novel
viral pathogen was demonstrated with the discovery of a
variant strain of PIV4. The whole coding region of the
variant strain was sequenced and showed that the majority
of publically available PIV4 PCR assays contained mis-
matches when aligned to this variant, which may lead to
decreased sensitivity and false negative results, thereby
underestimating the prevalence of PIV4.
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Additional file 1: Genome walking primers. PCR primers used to
amplify and sequence PIV4 strain QLD-01. All sequences are shown in the
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